Edition:
United States

Fresenius SE & Co KGaA (FREG.DE)

FREG.DE on Xetra

75.81EUR
11:35am EDT
Change (% chg)

€-0.17 (-0.22%)
Prev Close
€75.98
Open
€75.68
Day's High
€76.14
Day's Low
€75.54
Volume
752,804
Avg. Vol
991,238
52-wk High
€79.49
52-wk Low
€60.00

Latest Key Developments (Source: Significant Developments)

Fresenius says expect pronounced summer slump at Quironsalud
Wednesday, 3 May 2017 09:00am EDT 

May 3 (Reuters) - Fresenius CEO in analyst call:Says Q1 Quironsalud performance can’t be extrapolated to FY, expect a quite pronounced summer slump.  Full Article

Telefonica Deutschland says its CFO has a contract through end-2018
Thursday, 27 Apr 2017 06:00am EDT 

April 27 (Reuters) - Telefonica Deutschland in response to Manager Magazin report saying CFO Rachel Empey will be named new CFO of Fresenius FREG.DE:Says Rachel Empey has an employment contract with Telefónica Deutschland Holding AG until 31 December 2018.Says there has been no discussion between Telefónica Deutschland and Fresenius.Source text for Eikon: ID:nEQc39vRk.  Full Article

Akorn deal to pay Fresenius Kabi AG termination fee of $129 mln under specified circumstances
Monday, 24 Apr 2017 05:38pm EDT 

April 24 (Reuters) - Akorn Inc : :Akorn - deal with Fresenius Kabi provides under specified circumstances, co to be required to pay Fresenius Kabi AG termination fee of $129 million.  Full Article

Fresenius confirms discussions concerning potential acquisition of Akorn
Friday, 7 Apr 2017 04:54pm EDT 

Fresenius Se : Co and Akorn Inc don't intend to make any additional comments regarding these negotiations unless and until it is appropriate to do so . Currently in discussions with Akorn concerning a potential acquisition of Akorn . Confirms that Fresenius Kabi is currently in discussions with Akorn Inc concerning a potential acquisition of Akorn .No assurance any transaction will result from these discussions or as to terms of any such transaction.  Full Article

Fresenius said to weigh a bid for U.S. generics maker Akorn - Bloomberg
Friday, 7 Apr 2017 02:15pm EDT 

:Fresenius said to weigh a bid for U.S. generics maker Akorn - Bloomberg.  Full Article

Fresenius FY 2016 sales up 5 pct at 29.1 billion euros
Wednesday, 22 Feb 2017 01:14am EST 

Fresenius SE : FY sales 29.1 billion euros ($30.68 billion) (+5 pct, +6 pct in constant currency) . FY EBIT 4,327 million euros (+9 pct, +10 pct in constant currency), net income 1,593 million euros (+12 pct, +13 pct in constant currency) . Dividend proposal +13 pct to 0.62 euros per share . Q4 sales 7.7 billion euros (+7 pct, +6 pct in constant currency) . Outlook 2017: sales growth of 15 pct to 17 pct in constant currency, net income growth of 17 pct to 20 pct in constant currency .Targets 2020: group sales: between 43 billion euros and 47 billion euros, group net income: between 2.4 billion euros and 2.7 billion euros.  Full Article

Fresenius sets initial conversion price of €500 million convertible bonds
Thursday, 2 Feb 2017 01:04pm EST 

Fresenius Se & Co Kgaa : Fresenius says initial conversion price of €500 million equity-neutral convertible bonds due 2024 has been determined to be €107.0979 Further company coverage: [FREG.DE] ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;)).  Full Article

Fresenius says Quironsalud to be consolidated as of Feb. 1
Tuesday, 31 Jan 2017 10:27am EST 

Fresenius SE : Says closes acquisition of Quironsalud . Says Quironsalud will be consolidated as of February 1, 2017 . Says 400 million eur balance of purchase price was paid in the form of 6.1 million new Fresenius shares issued today Further company coverage: [FREG.DE] ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;)).  Full Article

Fresenius says placed 500 mln eur in convertible bonds
Thursday, 19 Jan 2017 11:40am EST 

Fresenius Se & Co Kgaa : Fresenius says placed €500 million equity-neutral convertible bonds due 2024 . Fresenius says issue price was fixed at 101.00% of the nominal value, corresponding to an annual yield to maturity of -0.142%d Further company coverage: [FREG.DE] ((frankfurt.newsroom@thomsonreuters.com; +49 69 7565 1270;)).  Full Article

Fresenius SE to issue 500 mln eur convertible bonds
Thursday, 19 Jan 2017 01:49am EST 

Fresenius SE & Co. KGaA : Fresenius announces issuance of equity-neutral convertible bonds . To issue 500 million eur convertible bonds due 2024 . Convertible bonds to have issue price 100 percent to 104.75 percent, conversion premium 45 percent . Bond to be used to finance Quironsalud, Spain's largest private hospital operator . Says to purchase call options on Fresenius shares to hedge high replayment obligation risk . Initial price to be determined after market close Feb 2, 2017 .Says to apply for bonds to be included in open market segment of Frankfurt Stock Exchange.  Full Article

More From Around the Web

BRIEF-Cerus provides U.S. business update

* A pending platelet additive solution shortage is expected to impact some U.S. blood centers producing intercept platelets